timolol has been researched along with y-39983 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, J; Almstead, ZY; Courtney, LF; Crist, M; Crosson, CE; Gardyan, M; Gopinathan, S; Gu, KJ; Hamman, BD; Harrison, BA; Key, B; Kimball, SD; Liu, Q; Liu, Y; Mabon, R; McKnight, B; Patel, N; Rawlins, DB; Rice, DS; Voronkov, MV; Whitlock, NA; Wilson, AG; Yates, PW; Zhang, Y; Zhou, J | 1 |
| Abuin, A; Eberhart, DE; Gerhardt, B; Harrison, B; Mixon, T; Rice, DS; Whitlock, NA; Wilson, A; Yu, XQ | 1 |
2 other study(ies) available for timolol and y-39983
| Article | Year |
|---|---|
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Glaucoma; Guanidines; In Vitro Techniques; Intraocular Pressure; Lim Kinases; Mice; Nitriles; Ocular Hypertension; Piperazines; Pyrimidines; Pyrroles; Structure-Activity Relationship; Swine; Urea | 2009 |
Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Amides; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Intraocular Pressure; Latanoprost; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscarinic Agonists; Pilocarpine; Prostaglandins F, Synthetic; Pyridines; rho-Associated Kinases; Timolol | 2009 |